[1]
Galli, M. et al. 2023. Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?. Bleeding, Thrombosis and Vascular Biology. 2, 3 (Aug. 2023). DOI:https://doi.org/10.4081/btvb.2023.90.